Invests primarily in biotechnology and biopharmaceutical companies worldwide, with the objective of long-term capital growth. The portfolio combines specialized sector expertise, fundamental research, and disciplined capital allocation to identify attractive opportunities across innovative and established segments of the sector.
Updated 2026-07-03